# Clinical Study to Evaluate the Safety and Effectiveness of Arcevo LSA

> **NCT07089576** · NA · RECRUITING · sponsor: **Artivion Inc.** · enrollment: 132 (estimated)

## Conditions studied

- Aortic Arch Aneurysm
- Aortic Arch Dissection
- Chronic Aortic Dissection
- Acute Aortic Dissection

## Interventions

- **DEVICE:** Arcevo™ LSA Hybrid Stent Graft System

## Key facts

- **NCT ID:** NCT07089576
- **Lead sponsor:** Artivion Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-11-04
- **Primary completion:** 2028-04
- **Final completion:** 2032-07
- **Target enrollment:** 132 (ESTIMATED)
- **Last updated:** 2026-04-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07089576

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07089576, "Clinical Study to Evaluate the Safety and Effectiveness of Arcevo LSA". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07089576. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*